Literature DB >> 3815366

ABH and Lewis blood group expression in colorectal carcinoma.

R Schoentag, F J Primus, W Kuhns.   

Abstract

The expression of ABO(H) and Lewis blood group antigens on 68 colorectal carcinomas from 63 patients was studied by immunohistochemical staining of tissue specimens. The pattern of antigen expression was as follows: ABH was expressed in normal tissue only in secretors and was expressed in the proximal but not distal colon. In tumors, there was net loss of ABH expression in the proximal and net gain in the distal colon. Some nonsecretor tumor tissue expressed ABH. Lewis expression was similar to but less strong than ABH. Its expression occurred only in secretors and in normal epithelium only in the proximal colon. In tumors there was net loss of antigen expression proximally and net gain in the distal colon. There was no expression of Lewisb in tumors of nonsecretors. Lewisa antigen was expressed throughout the normal colon in secretors and nonsecretors with no discernible difference between proximal and distal colon. In tumors, net loss of expression of Lewisa occurred throughout the colon. No inappropriate blood group expression was observed in this study. With few exceptions, H expression paralleled expression of A and B in non-0 patients. Metastatic tumor antigen expression was similar to that of the primary in most cases. Alterations in antigen expression were not clinically or histologically distinctive.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3815366

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  22 in total

1.  Blood group antigens, Lewisx and Lewisy in the diagnostic discrimination of malignant mesothelioma versus adenocarcinoma.

Authors:  D Jordon; J Jagirdar; M Kaneko
Journal:  Am J Pathol       Date:  1989-11       Impact factor: 4.307

2.  Comparison of the antimicrobial adhesion potential of human body fluid glycoconjugates using fucose-binding lectin (PA-IIL) of Pseudomonas aeruginosa and Ulex europaeus lectin (UEA-I).

Authors:  Batia Lerrer; Efrat Lesman-Movshovich; Nechama Gilboa-Garber
Journal:  Curr Microbiol       Date:  2005-08-02       Impact factor: 2.188

3.  Expression of H type 1 antigen of ABO histo-blood group in normal colon and aberrant expressions of H type 2 and H type 3/4 antigens in colon cancer.

Authors:  N Fujitani; Y Liu; S Toda; K Shirouzu; T Okamura; H Kimura
Journal:  Glycoconj J       Date:  2000-05       Impact factor: 2.916

4.  Expression of A and H blood-group and of CD44 antigens during chemical rat colonic carcinogenesis.

Authors:  F Hallouin; C Goupille; M le Cabellec; J Bara; J le Pendu
Journal:  Glycoconj J       Date:  1997-11       Impact factor: 2.916

5.  Altered expression of sialylated carbohydrate antigens in HT29 colonic carcinoma cells.

Authors:  D R Mack; P W Cheng; F Perini; S Wei; M A Hollingsworth
Journal:  Glycoconj J       Date:  1998-12       Impact factor: 2.916

6.  Modification of blood group A expression in human pancreatic tumor cell lines by inhibitors of N-glycan processing.

Authors:  C Schaffert; P M Pour; W G Chaney
Journal:  Int J Pancreatol       Date:  1997-02

7.  Expression of blood group antigens H-2, Le(y), and sialylated-Le(a) in human colorectal carcinoma. An immunohistochemical study using double-labeling techniques.

Authors:  H S Cooper; M J Malecha; C Bass; P L Fagel; Z Steplewski
Journal:  Am J Pathol       Date:  1991-01       Impact factor: 4.307

8.  Detection of metastasis-associated differences for receptors of glycoconjugates (lectins) in histomorphologically unchanged xenotransplants from primary and metastatic lesions of human colon adenocarcinomas.

Authors:  H J Gabius; T Ciesiolka; E Kunze; K Vehmeyer
Journal:  Clin Exp Metastasis       Date:  1989 Sep-Oct       Impact factor: 5.150

9.  An immunohistochemical study of the distribution of blood group substances and related antigens in primary colorectal carcinomas and metastatic lymph node and liver lesions, using monoclonal antibodies against A, B, H type 2, Le(a), and Le(x) antigens.

Authors:  T Nakagoe; K Fukushima; M Hirota; H Kusano; H Ayabe; M Tomita; S Kamihira
Journal:  J Gastroenterol       Date:  1994-06       Impact factor: 7.527

10.  DNA methylation of the ABO promoter underlies loss of ABO allelic expression in a significant proportion of leukemic patients.

Authors:  Tina Bianco-Miotto; Damian J Hussey; Tanya K Day; Denise S O'Keefe; Alexander Dobrovic
Journal:  PLoS One       Date:  2009-03-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.